These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 19245142)
1. Medicamentous treatment of chronic venous insufficiency using semisynthetic diosmin--a prospective study. Maksimović ZV; Maksimović M; Jadranin D; Kuzmanović I; Andonović O Acta Chir Iugosl; 2008; 55(4):53-9. PubMed ID: 19245142 [TBL] [Abstract][Full Text] [Related]
2. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids. Jantet G Angiology; 2002; 53(3):245-56. PubMed ID: 12025911 [TBL] [Abstract][Full Text] [Related]
4. [Multicentre observational study of Phlebodia 600 in treatment of patients with CEAP class C0-C3 chronic venous diseases]. Stoĭko IM; Talibov OB; Iashkin MN; Kudykin MN; Belentsov SM; Katel'nitskaia OV; Suchkov IA; Tolstikhin VI; Kletskin AÉ; Sevost'ianova KS Angiol Sosud Khir; 2018; 24(1):107-114. PubMed ID: 29688202 [TBL] [Abstract][Full Text] [Related]
5. RELIEF study: first consolidated European data. Reflux assEssment and quaLity of lIfe improvement with micronized Flavonoids. Jantet G Angiology; 2000 Jan; 51(1):31-7. PubMed ID: 10667641 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Kakkos SK; Nicolaides AN Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792 [TBL] [Abstract][Full Text] [Related]
7. [Derivatives of semi-synthetic diosmine in the treatment of patients with chronic venous insufficiency. The results of a prospective study--using phlebodia 600]. Pokrovskiĭ AV; Sapelkin SV Angiol Sosud Khir; 2005; 11(4):73-9. PubMed ID: 16474293 [TBL] [Abstract][Full Text] [Related]
8. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Lyseng-Williamson KA; Perry CM Drugs; 2003; 63(1):71-100. PubMed ID: 12487623 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"]. Carpentier PH; Mathieu M J Mal Vasc; 1998 Apr; 23(2):106-12. PubMed ID: 9608923 [TBL] [Abstract][Full Text] [Related]
10. [A double-blind study comparing the clinical efficacy of the preparation F-117 (hidrosmin) versus diosmin in the treatment of patients with peripheral venous disorders]. Honorato Pérez J; Arcas Meca R Rev Med Univ Navarra; 1990; 34(2):77-9. PubMed ID: 2130425 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of a Low-Dose Diosmin Therapy on Improving Symptoms and Quality of Life in Patients with Chronic Venous Disease: Randomized, Double-Blind, Placebo-Controlled Trial. Serra R; Ielapi N; Bitonti A; Candido S; Fregola S; Gallo A; Loria A; Muraca L; Raimondo L; Velcean L; Guadagna S; Gallelli L Nutrients; 2021 Mar; 13(3):. PubMed ID: 33808784 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of hidrosmin on chronic venous insufficiency of the lower limbs. Domínguez C; Brautigam I; González E; González JA; Nazco J; Valiente R; Boada J Curr Med Res Opin; 1992; 12(10):623-30. PubMed ID: 1633720 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy of micronized purified flavonoid fraction in treatment of chronic venous oedema]. Bogachev VI; Boldin BV; Turkin PI; Samenkov AI Angiol Sosud Khir; 2020; 26(2):86-94. PubMed ID: 32597888 [TBL] [Abstract][Full Text] [Related]
18. Association of Venous Disorders with Leg Symptoms: Results from the Bonn Vein Study 1. Wrona M; Jöckel KH; Pannier F; Bock E; Hoffmann B; Rabe E Eur J Vasc Endovasc Surg; 2015 Sep; 50(3):360-7. PubMed ID: 26141786 [TBL] [Abstract][Full Text] [Related]
19. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency. Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Di Renzo A; Ruffini I; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cornelli U; Hosoi M; Cacchio M Angiology; 2006; 57(2):131-8. PubMed ID: 16518519 [TBL] [Abstract][Full Text] [Related]
20. Plasma VEGF as a marker of therapy in patients with chronic venous disease treated with oral micronised flavonoid fraction - a pilot study. Shoab SS; Scurr JH; Coleridge-Smith PD Eur J Vasc Endovasc Surg; 1999 Oct; 18(4):334-8. PubMed ID: 10550269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]